Boston-based SAT/ACT prep organization Testive, Inc. is offering its popular proctored practice SATs and ACTs for free online, every Saturday through most of April. To sign up for the free online practice SAT or ACT test on 3/28, please register at www.testive.com/saturday. Read more >>
eSight Corporation, the world’s leading vision enhancement platform, today announces the launch of #eSightTogether, a place for connection and support during the COVID-19 outbreak. Read more >>
A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will be presenting at this year's Spring Investor Summit on March 25th-26th. During the current climate of concern, The Spring Investor Summit will now take place virtually, featuring over 500 registered executives and investors. Read more >>
Pixability, the leading provider of software and insights for video advertising on YouTube and Connected TV, today announced that Mike Baker, former CEO and Co-Founder of Dataxu, joined the company’s Board of Directors. Read more >>
In an effort to improve education access for those whose schools are closing, Boston-based SAT/ACT prep organization Testive, Inc. will be offering its popular proctored practice SATs and ACTs for free online every Saturday through most of April. Testive is an online test prep organization focusing exclusively on the SAT and ACT. Read more >>
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the appointment of Pete Salzmann, M.D., MBA, to its Board of Directors. Dr. Salzmann brings 20 years of industry experience and currently serves as Chief Executive Officer of Immunovant (IMVT), a biopharmaceutical company focused on developing therapies for patients with autoimmune diseases. Read more >>
Emovi, Inc., a global medical device company, today announced it has signed an exclusive European distribution agreement with Macopharma for its flagship medical device, KneeKG. Macopharma will be the exclusive KneeKG distributor in Italy, France, Germany, Poland, Spain, and the UK. Read more >>
The first patient has been dosed in a Phase 2 study testing NLY01, an investigational compound with a new mechanism of action designed to stall the progression of Parkinson’s disease. NLY01, being developed by Neuraly, could prevent nerve cell loss in the brain by stopping the toxic activation of immune cells. Read more >>
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.